William Blair Downgrades Sarepta Therapeutic (SRPT) to Market Perform
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $21.33 +1.43%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
William Blair downgraded Sarepta Therapeutic (NASDAQ: SRPT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $19.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Double Downgrades Myriad Genetics (MYGN) to Underweight, 'Major Strategic Action Likely Needed'
- BofA Securities Downgrades PG&E Corporation (PCG) to Neutral, 'A comprehensive reform opportunity falls short'
- UBS Downgrades AREIT Inc (AREIT:PM) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
